[Nontuberculous mycobacteria].

K Emmerich, M Fabri
Author Information
  1. K Emmerich: Klinik und Poliklinik für Dermatologie und Venerologie, Universität zu Köln, Kerpener Str. 62, 50937, Köln, Deutschland.
  2. M Fabri: Klinik und Poliklinik für Dermatologie und Venerologie, Universität zu Köln, Kerpener Str. 62, 50937, Köln, Deutschland. mario.fabri@uk-koeln.de.

Abstract

Dermatologically relevant nontuberculous mycobacteria (NTM) include Mycobacterium marinum and Mycobacterium ulcerans and different rapidly growing mycobacteria (RGM). RGM are widely present in the environment and are facultative pathogenic. Diagnostic detection of nontuberculous mycobacteria is frequently challenging. Immune-competent individuals mostly develop localized infections. Immune-suppressed patients may present with severe and disseminated disease. In these cases, rapid initiation of medical treatment is important. Moreover, infections with the more aggressive Mycobacterium ulcerans should be treated early. Due to the risk for the development of inducible antibiotic resistance, antibiotic regimes for NTM infections typically require at least two drugs. Surgical treatment should also be considered. This article discusses clinical presentation, diagnostic workup, and in particular antibiotic treatment options for dermatologically relevant infections caused by NTM.

Keywords

References

  1. Eur J Dermatol. 2006 Jan-Feb;16(1):79-83 [PMID: 16436349]
  2. N Engl J Med. 2002 May 2;346(18):1366-71 [PMID: 11986410]
  3. Science. 1999 Feb 5;283(5403):854-7 [PMID: 9933171]
  4. Curr Infect Dis Rep. 2014 Nov;16(11):438 [PMID: 25339245]
  5. Tuber Lung Dis. 1992 Jun;73(3):141-4 [PMID: 1421346]
  6. Clin Infect Dis. 2000 Aug;31(2):439-43 [PMID: 10987702]
  7. Eur J Clin Microbiol Infect Dis. 2013 Feb;32(2):161-88 [PMID: 23139042]
  8. Clin Exp Dermatol. 2013 Mar;38(2):140-2 [PMID: 22831709]
  9. Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416 [PMID: 17277290]
  10. Arch Dermatol. 2003 May;139(5):629-34 [PMID: 12756100]
  11. Scand J Infect Dis. 2001;33(3):232-3 [PMID: 11303818]
  12. Annu Rev Microbiol. 1998;52:453-90 [PMID: 9891805]
  13. Int J Dermatol. 2000 May;39(5):343-7 [PMID: 10849123]
  14. Am J Ophthalmol. 2001 Dec;132(6):819-30 [PMID: 11730644]
  15. Expert Rev Anti Infect Ther. 2014 Jul;12(7):855-65 [PMID: 24918117]
  16. J Infect Dev Ctries. 2010 Sep 03;4(8):521-5 [PMID: 20818105]
  17. J Am Acad Dermatol. 2010 Mar;62(3):501-6 [PMID: 19733936]
  18. Expert Opin Pharmacother. 2012 May;13(7):967-86 [PMID: 22519767]
  19. J Dtsch Dermatol Ges. 2016 Dec;14 (12 ):1227-1236 [PMID: 27992147]
  20. Clin Infect Dis. 2006 Jun 15;42(12):1756-63 [PMID: 16705584]
  21. BMJ. 2010 Oct 26;341:c5483 [PMID: 20978041]

MeSH Term

Anti-Bacterial Agents
Combined Modality Therapy
Dermatologic Surgical Procedures
Diagnosis, Differential
Evidence-Based Medicine
Humans
Mycobacterium Infections, Nontuberculous
Nontuberculous Mycobacteria
Skin Diseases, Bacterial
Treatment Outcome

Chemicals

Anti-Bacterial Agents

Word Cloud

Created with Highcharts 10.0.0MycobacteriuminfectionsmycobacteriaNTMulceranstreatmentantibioticrelevantnontuberculousmarinumRGMpresentDermatologicallyincludedifferentrapidlygrowingwidelyenvironmentfacultativepathogenicDiagnosticdetectionfrequentlychallengingImmune-competentindividualsmostlydeveloplocalizedImmune-suppressedpatientsmayseveredisseminateddiseasecasesrapidinitiationmedicalimportantMoreoveraggressivetreatedearlyDueriskdevelopmentinducibleresistanceregimestypicallyrequireleasttwodrugsSurgicalalsoconsideredarticlediscussesclinicalpresentationdiagnosticworkupparticularoptionsdermatologicallycaused[Nontuberculousmycobacteria]AntibioticsBuruliulcerFishtankgranuloma

Similar Articles

Cited By